Turning Pennies into dollars: (PINKSHEETS: CVSC), (PINKSHEETS: EESO), (PINKSHEETS: ERHE), (PINKSHEETS: LSCG), (PINKSHEETS: QBIK), and (PINKSHEETS: SYBD).
Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559
For more info: http://cvsc.realpennies.com
Mar 25, 2008 -- Cardiovascular Sciences, Inc. (PINKSHEETS: CVSC), a client company of the award-winning University of Central Florida Technology Incubator program, is enthused to announce that the company has reached an operating agreement with Med. Tech. Enterprises, Inc. Under this agreement, Cardiovascular Sciences, Inc. will immediately assume all daily operations of Med. Tech. Enterprises, Inc. Under this agreement, earnings will accrue to the benefit of Cardiovascular Sciences, Inc.
Cardiovascular Sciences, Inc. is already well underway in developing and producing a proprietary line of health-related products. Mr. Eric Edelmann, president of Med. Tech. Enterprises, stated, "With all the recent advances and impressive data that have become available on nutritionals, supplements and anti-oxidants, it is appropriate and even exciting to team up with a company like Cardiovascular Sciences to bring our own product line of quality and effective health products to market."
The Company's CEO, Dr. Larry Hooper, expressed, "This is a very positive step forward for Cardiovascular Sciences and its shareholders. At the same time, we will continue to develop our primary, post-surgical anti-adhesion technology which stands to propel Cardiovascular Sciences as a leading innovator in medical technology."
About Cardiovascular Sciences
Cardiovascular Sciences, Inc. is an advanced medical device company which is developing a novel technology platform to address the problem of post-surgical and post-traumatic adhesions. Adhesions and the complications of adhesions are a significant problem worldwide for a wide range of specialists, including general surgeons, cardiothoracic surgeons, orthopedic, plastic, and ophthalmologic and otolaryngology specialists to name just some of them. In addition, the veterinary field has a tremendous need for a product that can prevent similar problems in a wide variety of animals. The Company's unique materials and processes promise a more cost-effective and decidedly more efficient and capable means to deal with a problem that has been so devastating to so many. Current sponsored research at the University of Central Florida (UCF) and previously at other institutions indicate that The Company is on the right path and progressing well.
In addition to the anti-adhesion technology, The Company owns technology in a variety of other areas, including thrombo-resistant coatings, enhanced intra-arterial balloon pumping catheters, cell engineered vascular tissues, and a method for improved recovery of the heart following cardioplegia.
For more info: http://eeso.realpennies.com
Mar 28, 2008 -- Enzyme Environmental Solutions Inc. (PINKSHEETS: EESO) CEO Jared Hochstedler announced today that the company's new order flow and sales pipeline has expanded faster than originally expected.
Hochstedler commented, "Our experienced sales team is doing a wonderful job filling our sales pipeline with Fortune 500 companies that are pushing to convert to 'Green' products either for self use or sales distribution. The sales are coming from a diverse group across many industries. We are well positioned and are in the right place at the right time. EESO is a 'Green' conscience company because I saw the need many years ago and knew it would finally catch on. With orders already on the books, 2008 revenues should top $8 million; however with the sales pipeline and meetings scheduled, 2009 revenues could exceed my wildest dreams of over $30 million."
Hochstedler went on, "With the collapse of the glacier recently in the news, I know in my heart that something has to change and be done to protect our natural resources and environment. I believe manufacturing sustainable products is only one of the answers but is one easy step that we can all participate in. This is an exciting time for our company. We continue to get calls from all over the world inquiring about our products and my travel schedule is filling up. We are moving our production into our new facility with about 9,000 square feet this weekend (sooner than anticipated) in order to handle the unexpected increase of new orders. Please keep a watch on the website for the announcement of our Grand Opening and open house. I would like to invite all who can make it to come and visit with us. Negotiations on the Test Site announced earlier are moving forward but not yet finalized. I am really looking forward to having that asset on the books and building value for shareholders."
For more info: http://erhe.realpennies.com
Mar 27, 2008 -- The following update on Company activities was issued by Nicolae Luca, interim chief executive officer of ERHC Energy Inc. (PINKSHEETS: ERHE), on Thursday, March 27, 2008.
To ERHC Shareholders: "I am pleased once again to provide an update on the recent progress of ERHC Energy Inc.
"Our team continues to make progress toward exploration of some of our assets in the Gulf of Guinea, off the coast of West Africa. ERHC Energy's assets in the Gulf of Guinea include interests in the deepwater Joint Development Zone (JDZ) as well as interests in the territorial waters of Sao Tome and Principe known as the Exclusive Economic Zone (EEZ). To date, attention has been focused on JDZ Blocks 2, 3 and 4.
"JDZ Block 4 is most likely to be the first of our exploratory drilling locations. ERHC has a 26.7 percent (1) participating interest in JDZ Block 4. Our technical partner, Addax Petroleum, an experienced exploration and production company with significant interests throughout the JDZ, is the operator of JDZ Block 4. Addax executives have indicated that drilling could commence as early as the fourth quarter of this year. The Joint Development Authority (JDA), which was set up by the governments of Nigeria and Sao Tome and Principe to administer the JDZ, has approved the first drilling location, the Kina Prospect.
"Initial exploration of JDZ Block 2, in which ERHC Energy has a 22 percent participating interest, is currently expected to commence in 2009. Sinopec Corp. is the operator of JDZ Block 2. As we have stated previously, Sinopec and Addax Petroleum jointly contracted the Aban Abraham deepwater drillship, which continues to undergo refurbishment in Singapore. Discussions continue regarding the specific drilling location in JDZ Block 2.
"In JDZ Block 3, in which ERHC Energy has a 10 percent participating interest, the JDA has approved the first well location at what is known as the Lemba Prospect. Anadarko is the operator of JDZ Block 3 and has not disclosed a potential timeline for exploration.
"If you have not recently visited the ERHC Web site, I encourage you to review the latest seismic images that have been disclosed by our technical partner, Addax Petroleum, at www.erhc.com/jdzprospectivity. The images showcase what geologists and engineers, using advanced technologies, have determined lies beneath 5,000 feet of water and sand on the bottom of the Gulf of Guinea.
"ERHC remains interested in diversifying its asset and investment portfolio. As reported several months ago, ERHC's board of directors approved the reformulation of ERHC's business plan and expansion of strategic focus in August 2007. Greater flexibility was therefore granted to the Company's leadership, letting us explore opportunities beyond the Gulf of Guinea. Most recently, after due consideration and technical appraisal of a proposal to acquire a significant stake in a company pursuing mining investments in South East Asia, ERHC decided not to pursue the proposal. Going forward, ERHC will continue to consider opportunities in mining and minerals in addition to possible acquisitions in oil and gas.
"Plans are taking shape for ERHC Energy's annual shareholders' meeting on April 22, 2008. The requisite notice of meeting and proxy statement were filed with the U.S. Securities and Exchange Commission on March 17, 2008. The documentation has been mailed to all shareholders of record as of that date. The meeting will be held at the Renaissance Houston Hotel in Houston, Texas. We hope to see you there.
"ERHC Energy's annual report for 2007 has been completed and is also being sent to shareholders of record as of March 17, 2008. The annual report extends the Company's theme, 'Deep Opportunity.' The annual report continues our telling of the ERHC story and we encourage you to pass it along to others.
"Speaking of telling the ERHC story, the ERHC Energy staffers were doing a lot of that at Nigeria Oil & Gas 2008, a major conference and exhibition in Abuja, Nigeria where ERHC had a significant presence as sponsor and exhibitor. Some photographs from the event have been posted on our Web site and if you have not already seen them, please do so. According to conference organizers, the event attracted nearly 4,400 visitors, approximately 1,100 conference delegates and more than 100 journalists. It was an enormous success. Stories featuring ERHC Energy have already appeared in a number of trade publications.
"And finally, we have received a number of questions from shareholders regarding the significance of a photograph used in various marketing materials and posted online in February. As we have consistently stated, ERHC's management continues to explore options, proposals and prospects that might advance the interests of the Company and our shareholders. It is important to note, however, that ERHC Energy has not signed any letters of intent (LOIs), memoranda of understanding, undertakings or any other form of legal obligation related to any information or transaction that might appear to be depicted in the photograph. In the event that the ERHC leadership signs or enters into any LOIs or agreements related or giving rise to any material transaction, we will publicly disclose that information by the requisite means of dissemination.
"On behalf of the entire ERHC Energy family, thank you for your ongoing trust and support."
Sincerely, Nicolae Luca Acting Chief Executive Officer.
For more info: http://lscg.realpennies.com
March 26, 2008 -- Lighting Science Group Corp. (PINKSHEETS: LSCG) Combining innovative light- emitting diode (LED) illumination and nature-inspired artistry, Sacramento's U.S. Bank Tower will feature a dynamic new large-scale architectural lighting facade. The massive light sculpture crowning the building located at 621 Capitol Mall in the Capital City of the State of California is the latest achievement and creative vision of renowned artist Michael Hayden. The sculpture is being enabled by Lighting Science Group (OTC Bulletin Board: LSCG) (LSG), a global innovator in providing intelligent LED lighting solutions.
LSG and Hayden's collaboration is two-part, in the seven-story Lobby will be an LED lighting display that visually replicates the sinuous curves and rushing water of the nearby American and Sacramento rivers that wind through and around the city, called "The RAPIDS". When completed, the other display, titled "LUMETRIC RIVER" will cover the building's South-facing louvered top with a LED video projection of rushing river water that will be visible at night from miles away. The exterior lighting elements feature LSG's new range of high-power linear fixtures. On the interior, Hayden will utilize 200 of LSG's 20-inch-square tiles, (called 'Chiclets' by HAYDEN), coupled with LSG's proprietary stream control system.
"I've been designing lumetric installations for more than 40 years, and Lighting Science Group is an instrumental partner in helping to bring my artistic vision to life," said Hayden. "The Capitol Mall project was particularly challenging, and LSG worked closely with me and the building's management to ensure the results were just how we had envisioned."
LSG has a long-term creative partnership with Hayden, who is best known for creating computer-controlled "Lumetric" sculptures. Their joint efforts have produced such innovative "architainment" installations like the interactive "GOSSAMER GALAXIES" at Radio Shack's corporate headquarters in Ft. Worth, Texas, which responds to the movement of people walking near it from all sides and is viewable from three floors.
Lighting Science Group anticipates that the Capitol Mall project installation will be completed by late April 2008.
"Working with artists like Michael Hayden underscores our core competencies, and we're proud to enable marquee installations around the world to advance the design possibilities and flexibility with LED-based products and solutions," said Govi Rao, chief executive officer of Lighting Science Group. "Integrating creative architectural designs with innovative LED technology in projects like "The RAPIDS" and "LUMETRIC RIVER" at the Capitol Mall is a great illustration of how this technology is changing the future of lighting"
About Lighting Science
Lighting Science Group Corporation (LSG) designs, manufactures and markets intelligent, environmentally friendly LED lighting solutions for consumer and professional applications. The Company's patented and patent-pending designs in power management, thermal management, controls and micro-electronics are engineered to enhance lighting performance, reduce energy consumption, lower maintenance costs and eliminate the use of hazardous materials. From concept to delivery, the company's unique value proposition is to deliver immediate cost savings and environmental benefits to the end-user. LSG has offices in New York City, New York; Rancho Cordova, California; Satellite Beach, Florida; Dallas, Texas; Tokyo and the United Kingdom.
About Michael Hayden
For more than three decades Michael Hayden has utilized and manipulated Light to be the most important and unifying constituent in all of his "Lumetric" Sculptures. He has had the pleasure of creating architectonic scaled sculptures in light, for publicly accessible sites on this continent, Europe and Asia that are measured in hundreds of feet and multiples of tons. Hayden has collaborated with Architects, Interior Designers, Construction (Civil) Engineers, Landscape Architects, Electronic Engineers and Technicians, Composers, Poets, as well as other Artists. He has also interfaced with Clients, incorporating their particular aspirations and concerns to develop unique "Lumetric" Sculptures that are readily understandable to people from all walks of life.
For more info: http://qbik.realpennies.com
Mar 28, 2008 -- Cubic Energy, Inc. (PINKSHEETS:QBIK) ("Cubic" or the "Company") announces today receipt of an independent report, prepared by a qualified reservoir engineer, estimating original gas in place (OGIP) for Cotton Valley (CV) sandstones and Bossier/Haynesville (BH) shales in Cubic's Johnson Branch acreage (comprising the majority of each of twelve 640-acre sections) located in Caddo Parish, Louisiana. The estimates received indicate OGIP for the BH ranges from 217 to 245 BCF/section. The estimates also indicate OGIP of 20 BCF/section for the CV. Cubic has a 49% working interest in its Johnson Branch acreage.
In its Johnson Branch acreage, Cubic has drilled twelve wells through the CV, with three of these wells penetrating deeper through the BH shales. To date, eight Johnson Branch wells have been completed as gas producers in Cotton Valley (CV) sandstones.
Additionally, Cubic has eight producing wells in the CV and Hosston formations of its Bethany Longstreet acreage.
Cubic Energy, Inc. is an independent company engaged in the development and production of, and exploration for, crude oil and natural gas. The Company's oil and gas assets and activity are concentrated primarily in Texas and Louisiana.
For more info: http://sybd.realpennies.com
Mar 28, 2008 -- Synthetic Blood International, Inc. (PINKSHEETS:SYBD) today announced the addition of two new members to the company's board of directors. The two are Drs. Bruce Spiess, M.D. and Gerald L. Klein, M.D. The company had been in discussions with the two about joining the board prior to the passing Sunday night of Robert Larsen.
Dr. Spiess is Virginia Commonwealth University Professor of Anesthesiology and Emergency Medicine , Director of Research (Anesthesiology) and Director of Virginia Commonwealth University Reanimation Engineering Shock Center (VCURES). He is the co-chair of the company's Scientific Advisory Board and has been conducting clinical trials using Oxycyte(R) in the treatment of Traumatic Brain Injury patients. Oxycyte is the company's perfluorocarbon (PFC) therapeutic oxygen carrier and blood substitute.
Dr. Klein is vice president of global medical and clinical affairs and chief medical officer for a biotherapeutics company headquartered in Research Triangle Park, NC. His responsibilities there include global clinical development and medical affairs. He previously was a clinical professor of medicine and pediatrics at the University of California at Irvine.
"I'm very pleased that two physicians of such prominence in clinical research and development have agreed to join our board," said Chris J. Stern, DBA, Synthetic Blood International's chairman and CEO. "Bob Larsen wanted the company to proceed aggressively with the clinical development of Oxycyte. The experience and insights of these additional board members will help guide us as we pursue our development strategy. I believe that these new board members both are among the best in their fields. Dr. Spiess has spent over 28 years in perfluocarbon research and is a world authority in tissue oxygenation. Dr. Klein is one of the foremost clinical affairs authorities in biotech today. We are just blessed to have them both aboard," said Dr. Stern.
Said Dr. Spiess, "All the members of the medical advisory board are enthusiastic about the use of Oxycyte as a revolutionary technology to deliver oxygen to the microcirculation thereby to treat diseases wherein up to now we have had limited abilities to make a difference. It will be a personal honor to liaison the medical advice from those lead physicians to the board of directors and vice versa. The members of the medical advisory board join me in mourning the passing of Robert Larsen. He was a consummate gentleman and visionary figure in translating L. C. Clark's discovery of PFC's gas carrying capabilities to a medical miracle and reality. The highest honors we can pay to both Robert Larsen and L. C. Clark are to see patients healed by Oxycyte."
About Synthetic Blood International
Synthetic Blood International is dedicated to commercializing innovative pharmaceuticals and medical devices in the field of oxygen therapeutics and continuous substrate monitoring. The Company has under development an oxygen therapeutic/blood substitute and a liquid ventilation product, and an implantable glucose sensor. These products are based upon core technologies that include biomedical applications for PFCs, and medical and industrial applications for biosensors. Each of the product candidates is designed with advantages over currently marketed products in major markets including acute respiratory distress syndrome, stroke, myocardial infarction, surgery, trauma, malignant tumors and diabetes.
Read our full disclaimer at: http://www.realpennies.com/start.html
Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html
Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html
Sponsored by: http://www.isthemarketopen.com
RealPennies .
Telephone: 1-800-940-6559
Matt /at/ realpennies.com
